Press releasePRNewswire
IGM Biosciences LLC
IGMS · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNTY, IGMS, SPTN, DNOW on Behalf of Shareholders
- Press releaseBusiness Wire
IGMS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of IGM Biosciences, Inc. is Fair to Shareholders
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc. - IGMS
- NewsAvi Kapoor
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
- NewsAvi Kapoor
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results
- NewsAvi Kapoor
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December
- NewsRishabh Mishra
US Stocks To Open On A Tentative Note As Traders Remain Cautious Ahead Of Friday's Crucial Jobs Data
- NewsAvi Kapoor
Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
- Press releaseGlobe Newswire
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
- Press releaseGlobe Newswire
IGM Biosciences to Present at Three Upcoming Investor Conferences
- NewsAvi Kapoor
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
- NewsAvi Kapoor
Crude Oil Up 2%; Siyata Mobile Shares Jump
- NewsAvi Kapoor
Dow Dips Over 300 Points; Viad Shares Spike Higher
- NewsAvi Kapoor
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
- NewsAvi Kapoor
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
- Press releaseGlobe Newswire
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
- NewsSurbhi Jain
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
- Press releaseGlobe Newswire
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
- News
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
- News
What 4 Analyst Ratings Have To Say About IGM Biosciences
- Press releaseGlobe Newswire
IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
- NewsAvi Kapoor
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.